Search





Search





Markets
/
Stocks
/
nasdaq-mdt
/

Medtronic PLC

MDT

Add to Watchlist

81.145USD

+3.135+4.02%

Market hours （ET）Quotes delayed by 15 min

104.14BMarket Cap

22.55P/E TTM



Medtronic PLC

81.145

+3.135+4.02%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

Intraday

30m

Today

+4.02%

5 Days

+6.80%

1 Month

+1.43%

6 Months

-20.42%

Year to Date

-15.53%

1 Year

-5.14%

TradingKey Stock Score of Medtronic PLC

Currency: USD Updated: 2026-06-03

Key Insights

Medtronic PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 105.07.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Medtronic PLC's Score

Industry at a Glance

Industry Ranking

21 / 203

Overall Ranking

77 / 4569

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

44°C



Very Low

Very High

Neutral

Medtronic PLC Highlights

StrengthsRisks

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 33.54B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.

Undervalued

The company’s latest PE is 21.66, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.12B shares, decreasing 3.05% quarter-over-quarter.

Held by Scotia Canadian Dividend Fund

Star Investor Scotia Canadian Dividend Fund holds 118.91K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.48.

Analyst Rating

Based on 33 analysts

Buy

Current Rating

105.068

Target Price

+42.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Medtronic PLC News

TradingKey The Week on Wall Street: Ceasefire Hopes, AI Boom Lift US Stocks to New Highs; Inflation and Policy Risks Remain

TradingKey - US markets were closed on Monday, May 25, for Memorial Day. Geopolitical optimism surrounding US-Iran diplomatic talks continued to influence markets, with hopes for a ceasefire or deal regarding the Strait of Hormuz. Kevin Warsh, who was sworn in as Federal Reserve Chair on Friday, May

TradingKeyMon, Jun 1

[IN-DEPTH ANALYSIS] Riding the Wave: How Medtronic Capitalizes on the Aging Population

TradingKey - Against the backdrop of the global aging trend and the continuous rise in the incidence of chronic diseases, Medtronic's product portfolio precisely meets the growing demand for diagnosis and treatment. Relying on its global supply chain network and years of accumulated technological...

TradingKeyMay 26, 2025